期刊文献+

肝硬化患者血管紧张素Ⅱ-RIA水平与门脉血流动力学的关系 被引量:1

The relationship of angiotension-Ⅱ to portal hypertension in patients with liver cirrhosis
下载PDF
导出
摘要 目的 :探讨肝硬化门脉高 (PTH)的血流动力学变化及其与血中AT Ⅱ的关系。方法 :4 8例肝硬化PTH患者 (代偿期 18例、失代偿期 30例 )及 32例正常人作为研究对象 ,应用双功能多普勒测定门、脾静脉血流量 (PVBF&SVBF) ,同步测定血中AT Ⅱ的水平 ,并分析PVBF&SVBF与AT Ⅱ的相关性。结果 :门脉系统高血流动力学改变存在于肝硬化PTH发病的始终 ,代偿期显著下降的AT Ⅱ与门脉高血流动力学变化无相关性 ,失代偿期显著升高的AT Ⅱ与门脉高血流动力变化呈正相关。结论 :此研究对临床诊治有指导意义。 Objective:To study the relationships of portal hypertensions to vasoactive substances-angiotensin(AT-Ⅱ)in cirrhosis patients.Methods:48 patients with liver cirrhosis(LC)(including 18 patients with compensated LC and 30 patients with decompensated LC) and 32 normal controls(NC) were studied. Color duplex doppler ultrasonography was used to study portal venous and splenic venous blood flow(PVBF and SVBF).Also,the blood concentration of AT-Ⅱ was detected.Then,analyze the correlation between PVBF and SVBF to AT-Ⅱ.Results:Portal hyperdynamic exists in cirrhosis patients from beginning to the end. Low level of AT-Ⅱ in compensated LC patient has no relation with portal hyperdynamic, high level of AT-Ⅱ in decompensated LC has positive relation with portal hyperdynamic.Conclusion:This study has directed significance of clinical treatment and diagnosis.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2003年第12期865-866,869,共3页 Chinese Journal of Immunology
关键词 肝硬化 门脉高压 血管紧张素 Liver cirrhosis Portal hypertension Angiotensin
  • 相关文献

参考文献3

二级参考文献3

共引文献19

同被引文献16

  • 1Oren R, Hilzenrat N, Maaravi Yet al. Haemodynamic effects of hypothyroidism induced by methimazole in normal and portal hypertensive rats[J]. Dig Dis Sci, 1995,40(9):1941-1945.
  • 2Kelly GS, Peripheral metabolism of thyroid hormones: A review [J]. Altern Med Rev, 2000,5(4):306-333.
  • 3Langer P, Foldes O, Gschendtova K. Effect of ethanol and linoleic acid on changes in biliary excretion of iodothyronines possibly related to thyroxine deiodination in rat liver[J]. Horm Metab Res,1988,20(4): 218-220.
  • 4Hegedus L. Decreased thyroid gland volume in alcoholic cirrhosis of the liver[J]. J Clin Endocrinol Metab, 1984,58(5) :930-933.
  • 5Bianchi GP, Zoli M, Marchesini G, et al. Thyroid gland size and function in patients with cirrhosis of the liver[J]. Liver, 1991,11(2): 71-77.
  • 6Sabba C, Ferraioli G, Genecin P, et al. Evaluation of postprandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: An operator-blind echo-Doppler study [J].Hepatology, 1991,13(4): 714-718.
  • 7Guevara M, Bru C, Gines P, et al. Increased cerebrovascular resistance in cirrhotic patients with ascites[J]. Hepatology, 1998,28(1) :39-44.
  • 8Park KW, Dai HB, Ojamaa K, et al. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries [J] .Anesth Analg, 1997,85(4) :734-738.
  • 9Wesche MFT, Wiersinga WM, Smitst NJ. Lean body mass as a determinant of thyroid size[J]. Clin Endocrinol (Oxf), 1998, 48(6): 701-706.
  • 10Hegedus L. Thyroid gland volume and thyroid function during and after acute hepatitis infection [J]. Metabolism, 1986, 35 (6):495-498.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部